Cargando…

PSMA brings new flavors to PI3K signaling: A role for glutamate in prostate cancer

In this issue of JEM, Kaittanis et al. (https://doi.org/10.1084/jem.20171052) report a new signaling role for prostate-specific membrane antigen (PSMA), providing a mechanistic link between two major oncogenic pathways, as well as promising therapeutic implications for the diagnosis and treatment of...

Descripción completa

Detalles Bibliográficos
Autores principales: Palamiuc, Lavinia, Emerling, Brooke M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Rockefeller University Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5748867/
https://www.ncbi.nlm.nih.gov/pubmed/29222106
http://dx.doi.org/10.1084/jem.20172050
_version_ 1783289491827458048
author Palamiuc, Lavinia
Emerling, Brooke M.
author_facet Palamiuc, Lavinia
Emerling, Brooke M.
author_sort Palamiuc, Lavinia
collection PubMed
description In this issue of JEM, Kaittanis et al. (https://doi.org/10.1084/jem.20171052) report a new signaling role for prostate-specific membrane antigen (PSMA), providing a mechanistic link between two major oncogenic pathways, as well as promising therapeutic implications for the diagnosis and treatment of prostate cancer.
format Online
Article
Text
id pubmed-5748867
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher The Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-57488672018-07-02 PSMA brings new flavors to PI3K signaling: A role for glutamate in prostate cancer Palamiuc, Lavinia Emerling, Brooke M. J Exp Med News In this issue of JEM, Kaittanis et al. (https://doi.org/10.1084/jem.20171052) report a new signaling role for prostate-specific membrane antigen (PSMA), providing a mechanistic link between two major oncogenic pathways, as well as promising therapeutic implications for the diagnosis and treatment of prostate cancer. The Rockefeller University Press 2018-01-02 /pmc/articles/PMC5748867/ /pubmed/29222106 http://dx.doi.org/10.1084/jem.20172050 Text en © 2018 Palamiuc and Emerling http://www.rupress.org/terms/https://creativecommons.org/licenses/by-nc-sa/4.0/This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms/). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 International license, as described at https://creativecommons.org/licenses/by-nc-sa/4.0/).
spellingShingle News
Palamiuc, Lavinia
Emerling, Brooke M.
PSMA brings new flavors to PI3K signaling: A role for glutamate in prostate cancer
title PSMA brings new flavors to PI3K signaling: A role for glutamate in prostate cancer
title_full PSMA brings new flavors to PI3K signaling: A role for glutamate in prostate cancer
title_fullStr PSMA brings new flavors to PI3K signaling: A role for glutamate in prostate cancer
title_full_unstemmed PSMA brings new flavors to PI3K signaling: A role for glutamate in prostate cancer
title_short PSMA brings new flavors to PI3K signaling: A role for glutamate in prostate cancer
title_sort psma brings new flavors to pi3k signaling: a role for glutamate in prostate cancer
topic News
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5748867/
https://www.ncbi.nlm.nih.gov/pubmed/29222106
http://dx.doi.org/10.1084/jem.20172050
work_keys_str_mv AT palamiuclavinia psmabringsnewflavorstopi3ksignalingaroleforglutamateinprostatecancer
AT emerlingbrookem psmabringsnewflavorstopi3ksignalingaroleforglutamateinprostatecancer